Vaxcyte Inc. (PCVX)
NASDAQ: PCVX
· Real-Time Price · USD
33.23
1.08 (3.36%)
At close: Sep 05, 2025, 10:06 AM
3.36% (1D)
| Bid | 33.16 |
| Market Cap | 4.31B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -547.5M |
| EPS (ttm) | -4.11 |
| PE Ratio (ttm) | -8.09 |
| Forward PE | -5.54 |
| Analyst | Buy |
| Ask | 33.27 |
| Volume | 88,313 |
| Avg. Volume (20D) | 1,425,733 |
| Open | 32.50 |
| Previous Close | 32.15 |
| Day's Range | 32.42 - 33.36 |
| 52-Week Range | 27.66 - 121.06 |
| Beta | 1.21 |
About PCVX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PCVX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PCVX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-5.7%
Shares of vaccine companies are trading lower foll...
Unlock content with
Pro Subscription
4 weeks ago
-9.06%
Vaxcyte shares are trading lower after the company reported a Q2 EPS miss.
